GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arjo AB (STU:A39) » Definitions » Research & Development

Arjo AB (STU:A39) Research & Development : €13.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Arjo AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Arjo AB's Research & Development for the three months ended in Mar. 2024 was €3.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €13.3 Mil.


Arjo AB Research & Development Historical Data

The historical data trend for Arjo AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arjo AB Research & Development Chart

Arjo AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.26 11.21 9.74 10.46 13.32

Arjo AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.94 3.26 3.04 3.67 3.36

Arjo AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €13.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arjo AB  (STU:A39) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Arjo AB Research & Development Related Terms

Thank you for viewing the detailed overview of Arjo AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Arjo AB (STU:A39) Business Description

Traded in Other Exchanges
Address
Hans Michelsensgatan 10, Malmo, SWE, SE-211 20
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. It also offers services such as training in connection with product sales. Geographically, it derives a majority of revenue from Western Europe and also has a presence in North America; and the Rest of the World.

Arjo AB (STU:A39) Headlines

No Headlines